ABIVAX Société Anonyme (AAVXF PINK) stock market data APIs
$125.6407
0(0%)
as of February 23, 2026
Try our APIs with
free plan!
ABIVAX Société Anonyme Financial Data Overview
Price chart is built with
Anychart
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Prev. Close
125.6407
Open
125.6407
High
125.6407
Low
125.6407
52 wk Range
5.81-133.4
Market Cap
9 556 M
Shares Outstanding
79 073 K
Revenue
5 311 K
EPS
-2.4569
Beta
-0.42
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ABIVAX Société Anonyme (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ABIVAX Société Anonyme data using free add-ons & libraries
Get ABIVAX Société Anonyme Fundamental Data
ABIVAX Société Anonyme Fundamental data includes:
- Net Revenue: 5 311 K
- EBITDA: -217 952 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ABIVAX Société Anonyme News
New
ABIVAX Société Anonyme (ABVX): A Bull Case Theory
We came across a bullish thesis on ABIVAX Société Anonyme on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on ABVX. ...
ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 11 Best Performing Stocks in the Last 12 Months.ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Thera...
This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest.
Eli Lilly’s presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical giant could be looking to expand its footprint in the country. French outlet...
Abivax shares surge after report flags continued Eli Lilly takeover interest
Investing.com -- Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech. The stock soared more than 23% in Paris to ...
Get ABIVAX Société Anonyme fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
